Government bans sale and manufacture of pain killer Dextropropoxyphene
As per notification vide GSR No.332 (E) Dated 23 May 2013 Government had suspended the manufacture, sale and distribution of Dextropropoxyphene and formulations containing Dextropropoxyphene for human use.
Its sale already banned in the US, UK and other countries earlier.
Product permissions granted to the manufacturers and its loan licensees to manufacture this drug and its formulations also stand suspended.
The drug must be withdrawn from the market immediately as per notification of Government of India.
Recent Posts
How to Manufacture Class A & B Medical Devices in India: State FDA License Guide
A quick guide on the Class A & B Medical Device manufacturing license — covering State FDA rules, Form MD-3/MD-5, fees, and timelines for manufacturers. Every manufacturer entering India’s..
Importing Small Quantities of Cosmetics for R&D in India: NOC Requirements
A brief guide on Cosmetic import NOC India — covering when small quantity Cosmetic import for R&D testing bypasses full registration under Cosmetic rules 2020. Not every Cosmetic shipment into I..
The Cosmeceuticals Grey Zone: When a Cosmetic Claim Risks Becoming a Drug Claim
“Cosmeceutical” is a popular marketing word. It suggests something more powerful than an ordinary Cosmetic — a product that treats skin condition, not just improves appearance. The problem is th..
Get In Touch With Our Team
-
Email: contact@cliniexperts.com
-
Timings: 9 am to 6 pm (Monday to Friday)
-
Location: India: Delhi, Bangalore Global: USA, Singapore